Source:http://linkedlifedata.com/resource/pubmed/id/11827201
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2002-2-5
|
pubmed:abstractText |
In the present study we evaluated the performance of the new LCx HIV RNA quantitative kit (Abbott Laboratories, Delkenheim, Germany) for the quantitative detection of HIV-1 RNA in human plasma in comparison to the Cobas Amplicor HIV-1 Monitor assay (Roche Diagnostics, Branchburg, N.J.), including samples containing a variety of HIV-1 subtypes. LCx and Cobas were compared using archived EDTA plasma samples collected from HIV-infected patients. Considering the lower limit of the linear range of 50 copies/ml, the detection rate of the LCx was 139 out of 174 (79.9%) versus 131 out of 174 (75.3%) of the Cobas. Overall agreement was 95.4% (166/174) at a cut-off of 50 copies. LCx and Cobas results on clinical samples were found linearly associated (r2 = 0.900) and strongly correlated (r = 0.949). The mean viral load in the 174 frozen patient samples was 3.25 log10 copies/ml by LCx compared to 2.71 log10 copies/ml by Cobas. Considering only samples with a viral load > or =50 copies/ml, the average difference was -0.132 log copy/ml. Using a panel consisting of 9 plasma samples spiked with 9 different HIV-1 cultured isolates (A-H, and O) LCx detected the 9 subtypes with a high degree of precision, i.e., 9-33% coefficient of variation. As expected, the Cobas failed to detect the group O isolates. The results of the remaining samples showed a higher degree of variation (when testing four replicates of the subtype panel) than the LCx of 14.2-40.3%. Nevertheless, the results were comparable with the LCx data.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0300-8584
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
190
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-34
|
pubmed:dateRevised |
2007-2-21
|
pubmed:meshHeading |
pubmed-meshheading:11827201-DNA Ligases,
pubmed-meshheading:11827201-HIV Infections,
pubmed-meshheading:11827201-HIV-1,
pubmed-meshheading:11827201-Humans,
pubmed-meshheading:11827201-Nucleic Acid Amplification Techniques,
pubmed-meshheading:11827201-RNA, Viral,
pubmed-meshheading:11827201-Reagent Kits, Diagnostic,
pubmed-meshheading:11827201-Reproducibility of Results,
pubmed-meshheading:11827201-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11827201-Sensitivity and Specificity,
pubmed-meshheading:11827201-Viral Load
|
pubmed:year |
2001
|
pubmed:articleTitle |
Evaluation of the new LCx HIV RNA quantitative assay: comparison with the Cobas Amplicor HIV Monitor assay.
|
pubmed:affiliation |
Institute for Medical Virology, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|